Regulates price increases for prescription drugs.

Rhode Island Prescription Drug Price Regulation Bill

This bill would create rules to regulate how much the prices of prescription drugs can increase in Rhode Island. Under the proposal, drug price increases would be subject to oversight, meaning that companies could not simply raise prices without some form of review or approval. The goal is to bring greater accountability to how prescription drug prices are set and changed over time.

The bill would most directly affect Rhode Island residents who rely on prescription medications, particularly those who struggle to afford rising drug costs. It could also impact health insurance companies, pharmacies, and pharmaceutical manufacturers operating in the state. By placing limits or oversight on price increases, the bill aims to make medications more affordable and predictable for patients and insurers alike.

Currently, the bill has been introduced in the Rhode Island House of Representatives and referred to the House Health & Human Services Committee. The committee has recommended it be held for further study, meaning lawmakers want more time to review and discuss the details before moving it forward. A hearing was scheduled for March 2026. The bill builds on Rhode Island's existing Health Care Reform Act of 2004, which already established a framework for health care oversight in the state.